S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)

Omega Therapeutics (OMGA) News Today

$2.40
-0.12 (-4.76%)
(As of 03:09 PM ET)
SourceHeadline
globenewswire.com logoOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
globenewswire.com - April 9 at 7:00 AM
marketbeat.com logoOmega Therapeutics, Inc. to Post FY2024 Earnings of ($1.31) Per Share, Chardan Capital Forecasts (NASDAQ:OMGA)
marketbeat.com - April 4 at 9:14 AM
marketbeat.com logoOmega Therapeutics (NASDAQ:OMGA) Earns "Overweight" Rating from Piper Sandler
marketbeat.com - April 3 at 12:14 PM
marketbeat.com logoOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $7.00
marketbeat.com - April 1 at 9:10 AM
seekingalpha.com logoOmega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'
seekingalpha.com - March 31 at 9:07 AM
finance.yahoo.com logoWe Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
finance.yahoo.com - March 29 at 9:17 AM
investorplace.com logoOMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 29 at 2:01 AM
globenewswire.com logoOmega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
globenewswire.com - March 28 at 9:15 AM
finance.yahoo.com logoOMGA Apr 2024 12.500 call
finance.yahoo.com - March 16 at 12:21 AM
markets.businessinsider.com logoIntrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
markets.businessinsider.com - March 12 at 12:24 PM
globenewswire.com logoOmega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
globenewswire.com - March 6 at 7:00 AM
marketbeat.com logoOracle Investment Management Inc. Sells 147,449 Shares of Omega Therapeutics, Inc. (NASDAQ:OMGA)
marketbeat.com - March 1 at 12:26 PM
marketbeat.com logoOmega Therapeutics (NASDAQ:OMGA) Shares Up 0.9%
marketbeat.com - February 17 at 2:41 AM
benzinga.com logoHow Is The Market Feeling About Omega Therapeutics?
benzinga.com - January 26 at 7:26 PM
seekingalpha.com logoOmega Therapeutics: The Next Weight Loss Drug Runner
seekingalpha.com - January 16 at 7:00 PM
morningstar.com logoOmega Therapeutics Inc OMGA
morningstar.com - January 6 at 11:53 PM
finance.yahoo.com logoNovo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
finance.yahoo.com - January 5 at 3:24 PM
finance.yahoo.com logoOmega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
finance.yahoo.com - January 5 at 3:24 PM
msn.com logoOmega (NASDAQ:OMGA) Skyrockets After Research Deal With Novo Nordisk
msn.com - January 4 at 11:20 PM
realmoney.thestreet.com logoOmega collaboration with Novo Nordisk 'validation' of OEG platform, says Wedbush
realmoney.thestreet.com - January 4 at 6:18 PM
fool.com logoWhy Novo Nordisk Stock Crushed the Market Today
fool.com - January 4 at 6:18 PM
marketbeat.com logoOmega Therapeutics (NASDAQ:OMGA) Rating Reiterated by Wedbush
marketbeat.com - January 4 at 2:45 PM
ca.finance.yahoo.com logoOMGA Feb 2024 2.500 call
ca.finance.yahoo.com - January 4 at 1:17 PM
markets.businessinsider.com logoFamed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
markets.businessinsider.com - January 4 at 1:17 PM
finance.yahoo.com logoNovo Nordisk enters research partnerships with biotech firms
finance.yahoo.com - January 4 at 1:17 PM
finance.yahoo.com logoNovo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
finance.yahoo.com - January 4 at 1:17 PM
investorplace.com logoWhy Is Omega Therapeutics (OMGA) Stock Up 111% Today?
investorplace.com - January 4 at 10:02 AM
marketwatch.com logoOmega Therapeutics Stock Surges 99% Following Pact with Novo Nordisk to Treat obesity
marketwatch.com - January 4 at 8:17 AM
msn.com logoNovo Nordisk signs research deals on cardiometabolic diseases
msn.com - January 4 at 8:17 AM
markets.businessinsider.com logoNovo Nordisk Enters Collaboration Agreements With Omega And Cellarity
markets.businessinsider.com - January 4 at 8:17 AM
finance.yahoo.com logoOmega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 6:20 PM
finance.yahoo.com logoOmega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
finance.yahoo.com - December 4 at 5:35 PM
benzinga.com logoOmega Therapeutics Stock (NASDAQ:OMGA) Earnings Dates and Earning Calls
benzinga.com - November 24 at 3:35 PM
benzinga.com logoOmega Therapeutics Stock (NASDAQ:OMGA) Insider Trades
benzinga.com - November 24 at 5:35 AM
finance.yahoo.com logoOmega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
finance.yahoo.com - November 20 at 6:04 PM
finance.yahoo.com logoOmega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
finance.yahoo.com - November 13 at 9:18 AM
benzinga.com logoRecap: Omega Therapeutics Q3 Earnings
benzinga.com - November 9 at 1:52 PM
finance.yahoo.com logoOmega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
finance.yahoo.com - November 9 at 7:52 AM
finance.yahoo.com logoOmega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
finance.yahoo.com - November 9 at 7:52 AM
finance.yahoo.com logoOmega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC
finance.yahoo.com - October 16 at 8:52 AM
tmcnet.com logoOmega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD's The Liver Meeting® 2023
tmcnet.com - October 13 at 5:06 AM
finance.yahoo.com logoOmega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023
finance.yahoo.com - October 11 at 5:32 PM
msn.com logoOmega Therapeutics (OMGA) Price Target Increased by 10.98% to 13.26
msn.com - October 5 at 2:08 AM
finance.yahoo.com logoOmega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - October 4 at 9:08 PM
markets.businessinsider.com logoPromising Preliminary Data and Novel Mechanism of Omega Therapeutics’ OTX-2002 Bolster Analyst’s Buy Rating
markets.businessinsider.com - September 28 at 8:26 AM
markets.businessinsider.com logoOmega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial
markets.businessinsider.com - September 26 at 8:49 AM
finance.yahoo.com logoOmega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial
finance.yahoo.com - September 26 at 8:49 AM
marketbeat.com logo
marketbeat.com - September 26 at 6:56 AM
finance.yahoo.com logoOmega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26
finance.yahoo.com - September 25 at 7:15 PM
barrons.com logoOmega Therapeutics Inc.
barrons.com - September 24 at 11:28 PM
Get Omega Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter.

Your eBook: Mastering Earnings Announcements Trading (Ad)

Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).

Click Here to Claim Your FREE The Ultimate Strategy Guide To Trade Earnings E-Book .

OMGA Media Mentions By Week

OMGA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OMGA
News Sentiment

0.93

0.66

Average
Medical
News Sentiment

OMGA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OMGA Articles
This Week

1

1

OMGA Articles
Average Week

Get Omega Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OMGA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners